Friday November 21, 2014 |
08:00 | Registration |
|
08:50 | Opening |
Dr Laurent PROVINS (UCB, Braine-l'Alleud, Belgium) |
09:00 | L01 - GPCR-ligand Structures through the Looking Glass: Computer-Aided Prediction of GPCR-Ligand Interactions |
Dr Chris DE GRAAF (VU UNIVERSITY AMSTERDAM, Cambridge, United Kingdom) |
09:50 | L02 - Nanobodies to Study GPCR Transmembrane Signaling: From Structures to Function to Drugs |
Prof. Jan STEYAERT (VUB, Brussels, Belgium) |
10:40 | Coffee Break |
|
11:15 | OC01 - Discovery of Donecopride: Design of Dual 5-HT4R Agonists/AChE Inhibitors Multi-Target Directed Ligands for Alzheimer's Disease Treatment |
Prof. Christophe ROCHAIS (UNIVERSITY OF CAEN, Caen, France) |
11:35 | L03 - Dual A2A-NR2B Antagonists: Potential for Unprecedented Activity in Parkinson’s Disease |
Mr Joël MERCIER (UCB, BRAINE-L'ALLEUD, Belgium) |
12:25 | Sandwich Lunch |
|
14:00 | L04 - Biased Ligands, Allosteric Modulation: New Technological Approaches |
Dr Stephan SCHANN (DOMAIN THERAPEUTICS, Strasbourg, France) |
14:50 | OC02 - Novel Histamine H1-Receptor Fluorescent Antagonists for the Study of Receptor-Ligand Interactions |
Dr Leigh STODDART (UNIVERISITY OF NOTTINGHAM , Nottingham, United Kingdom) |
15:10 | OC03 - Identification of Modulators for SUCNR1 BY Screening of a SOSA Library with a Bioluminescent cAMP Assay |
Mrs Julie GILISSEN (ULG, Liege, Belgium) |
15:30 | Coffee Break and Poster Session |
|
16:05 | L05 - Developing Ligands to Validate the Role of Receptors for Long-chain Fatty Acids in the Treatment of Type II Diabetes |
Prof. Graeme MILLIGAN (UNIVERSITY OF GLASGOW, Glasgow, United Kingdom) |
16:55 | L06 - Positive Allosteric Modulators of mGlu2 Receptors for the Treatment of CNS Disorders |
Dr Daniel OEHLRICH (JANSSEN RESEARCH AND DEVELOPMENT, Beerse, Belgium) |
17:45 | Closing Remarks |
Prof. Koen AUGUSTYNS (UNIVERSITY OF ANTWERP, Antwerp, Belgium) |